Products and Services
Watch this video to see how easy it is to load the truCOLLECT-plus swab.
Patents issued and pending
Features & Benefits
Biomarker extraction from blood is the method of choice for researchers and clinicians, but the logistics of blood collection, stabilization, shipping, and biomarker extraction remain complex, expensive, and difficult to standardize. Blood collection methods for biomarker extraction require a professional phlebotomist, collection of large volumes of blood, and leak-proof overnight shipping on ice or cold-packs. This creates logistic and financial barriers for emerging biomarker application such as large scale genomic, pharmaceutical pre-clinical, and animal model studies. For example, the novel truCOLLECT system greatly simplifies blood collection, stabilization, and shipment while generating DNA yield and quality comparable to whole blood.
Comprehensive workflow, designed for biomarker extraction
SHIP & STORE
- Medical-grade 0.5MHz ultrasonic transducer
- Geometrically focused acoustic energy
- Short wavelength ideal for processing biological molecules
- Non-contact delivery of controlled focused acoustic energy
- Acoustically optimized sample vessel materials and design
- Consistent sample processing temperature (isothermal)
|Part #||Product Name||Description|
|520254||truCOLLECT™-plus Stabilization & Transport Kit (10)||Optimized for up to 80 ul of whole blood. Kit contains ten (10) truCOLLECT-plus caps/swabs with barcode and desiccant/storage container with tamper-evident indicator (10)|
|520259||truXTRAC DNA Kit for truCOLLECT-plus – Column (10)||Kit contains reagents and consumables required for DNA extraction and column-based purification from ten (10) truCOLLECT-plus caps/swabs with dry-stabilized whole blood|
|520260||truXTRAC DNA Kit for truCOLLECT-plus – Magnetic Bead (10)||Kit contains reagents and consumables required for DNA extraction and magnetic bead-based purification from ten (10) truCOLLECT-plus caps/swabs with dry-stabilized whole blood|
truCOLLECT-RUO for Pediatrics
Enabling comprehensive molecular profiling from precious samples
Pediatric Screening programs continue to show clinical relevance for treating disease early on in life. Molecular characterization of patient samples continues to show potential for advancement in the management of rare diseases, metabolic disorders, pediatric cancers and high-risk hematologic diseases1. As input requirements decrease, the use of comprehensive tools like whole exome and whole genome sequencing become more clinically relevant.
With our truCOLLECT device, Whole Genome Sequencing from infants without an additional blood draw is possible, allowing physicians the ability perform all of their current required screenings and biochemical assays from a single 1cc blood draw.
- Decrease turn-around time by up to 4 hours
- Reduce risks of contamination
- Simplified workflow
- Tightly controlled sample tracking
Single Day Workflow*
|Current Pediatric Screening with NGS
Two Day Workflow
|Sample Collection & Stabilization||5 minutes||1 hour|
|Purification||30 minutes||1.5 hours|
|NGS Sample Prep & Library Construction||2 to 2.5 hours||6 hours|
*Single day workflow is based on intra-hospital sample transfer. The truCOLLECT-RUO product is stable at room temperature and can be purchased as a specimen transport kit for inter-hospital transfer of samples.
|Collect and dry stabilize||Whole blood is transferred onto porous fiber followed by controlled desiccation in the storage container|
|Storage||Store at ambient temperature in the truCOLLECT storage container|
|Blood volume stored||up to 80 µl single device|
|DNA yield per stored unit||>1 µg on average|
|DNA MW||>1.5 kb; optional shearing to target size|
|Extraction and purification (time elapsed)||30 minutes|
|Sample tracking||2D barcode attached from collection to DNA extraction|
|truCOLLECT-plus and extraction kits||520245 (truCOLLECT-plus)
520259 (column-based purification)
520260 (bead-based purification)
In this poster, we introduce truCOLLECT™, a novel blood collection system which does not require a venous blood draw and greatly simplifies blood collection, standardizes dry stabilization, and simplifies shipment while delivering DNA yield and quality comparable to fresh whole blood
Here, we present two innovations that together overcome many of the drawbacks of the current DBS technology: (1) a novel sampling device for collecting capillary blood (truCOLLECT™) that provides integrated sample barcoding, eliminates the need for a drying period before shipment, and yields DNA and protein amounts similar to those seen with fresh blood; and (2) use of Adaptive Focused Acoustics (AFA™) for efficient release of biomarker from truCOLLECT™ devices as well as from conventional DBS (truXTRAC™ DBS). The AFA™-based extraction process is highly automated and allows batch processing with less than 30 min hands-on-time per 96 samples.
Covaris provides tools and technologies to improve pre-analytical sample preparation, enable novel drug formulations, and manage compounds in the drug discovery process.